Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Clorox (CLX)

Clorox elects Gina Boswell to board, effective May 19, 2025

Neutral Impact 2 of 5 leadership Written later

Clorox's board elected Gina Boswell, chief executive officer of Bath & Body Works, as a director effective May 19, 2025, and appointed her to the Nominating, Governance and Corporate Responsibility Committee. The filing says the board will rise to 12 members with her appointment, and the filing does not discuss financial results.

Key points

  • Board elected Gina Boswell on May 11, 2025, effective May 19, 2025
  • Boswell, 62, is CEO of Bath & Body Works, Inc. and has prior senior roles at Unilever, Avon, Ford and Estée Lauder
  • Appointed to the Nominating, Governance and Corporate Responsibility Committee, effective May 19, 2025
  • Board size will increase to 12 members

The filing

CompanyClorox (CLX)
Form8-K, current report
Filed with the SECMay 12, 2025, 4:28 PM ET
Accession number0001206774-25-000357

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:12 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 12, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.